Clinical trials data
Trail Making Test in stroke trials: 156 registered studies
Every registered stroke study on ClinicalTrials.gov that names the Trail Making Test in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered stroke studies name it in an outcome measure
- 156
- Name it in a primary outcome, 25%
- 39 of 156
Tests named in the same studies
- 1
Digit Span Test56 studies, 15 as a primary outcome
- 2
Stroop Color-Word Test48 studies, 16 as a primary outcome
- 3
Verbal Fluency36 studies, 13 as a primary outcome
- 4
Verbal Learning29 studies, 7 as a primary outcome
- 5
Symbol Coding21 studies, 3 as a primary outcome
- 6
Picture Naming Test16 studies, 6 as a primary outcome
- 7
Category Fluency14 studies, 4 as a primary outcome
- 8
Task Switching Test12 studies, 4 as a primary outcome
- 9
Cancellation Test12 studies, 3 as a primary outcome
- 10
Corsi Block-Tapping Test10 studies, 2 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 2 | 0 |
| 2007 | 1 | 0 |
| 2008 | 2 | 0 |
| 2009 | 3 | 0 |
| 2010 | 1 | 1 |
| 2011 | 2 | 1 |
| 2012 | 2 | 0 |
| 2013 | 6 | 0 |
| 2014 | 2 | 0 |
| 2015 | 4 | 1 |
| 2016 | 6 | 1 |
| 2017 | 13 | 2 |
| 2018 | 8 | 2 |
| 2019 | 10 | 2 |
| 2020 | 10 | 5 |
| 2021 | 10 | 2 |
| 2022 | 14 | 3 |
| 2023 | 16 | 3 |
| 2024 | 11 | 3 |
| 2025 | 18 | 8 |
| 2026 | 15 | 5 |
Phases and study sizes
By phase
- Phase 217 studies, 2 as a primary outcome
- Phase 2/31 studies, 0 as a primary outcome
- Phase 37 studies, 1 as a primary outcome
- Phase 44 studies, 1 as a primary outcome
- Not applicable107 studies, 33 as a primary outcome
- Observational20 studies, 2 as a primary outcome
Participants per study
- Phase 288 median, 33 to 100
- Not applicable45 median, 30 to 89
- Observational150 median, 65 to 313
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Phase 2 | 17 | 88 | 33 to 100 |
| Not applicable | 106 | 45 | 30 to 89 |
| Observational | 20 | 150 | 65 to 313 |
When stroke trials measure it
Latest time point of each outcome
- Within a day17 outcomes, 4 as a primary outcome
- Up to 4 weeks31 outcomes, 14 as a primary outcome
- 1 to 3 months55 outcomes, 12 as a primary outcome
- 3 to 6 months18 outcomes, 3 as a primary outcome
- 6 to 12 months16 outcomes, 4 as a primary outcome
- 1 to 2 years5 outcomes, 0 as a primary outcome
- Over 2 years8 outcomes, 2 as a primary outcome
- No duration given6 outcomes, 0 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
150 of the 156 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting35 studies, 8 as a primary outcome
- Not yet recruiting10 studies, 4 as a primary outcome
- Active, not recruiting8 studies, 4 as a primary outcome
- Completed62 studies, 14 as a primary outcome
- Stopped early14 studies, 4 as a primary outcome
- Status unknown27 studies, 5 as a primary outcome
What they test
- Behavioral46 studies, 10 as a primary outcome
- Drug26 studies, 4 as a primary outcome
- Device36 studies, 9 as a primary outcome
- Dietary supplement2 studies, 1 as a primary outcome
- Procedure7 studies, 2 as a primary outcome
- Diagnostic test3 studies, 1 as a primary outcome
- Biological2 studies, 0 as a primary outcome
- Combination product1 studies, 0 as a primary outcome
- Genetic1 studies, 1 as a primary outcome
- Other55 studies, 21 as a primary outcome
- None given9 studies, 0 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- United States28 studies, 6 as a primary outcome
- Canada18 studies, 0 as a primary outcome
- Italy13 studies, 5 as a primary outcome
- Taiwan12 studies, 8 as a primary outcome
- France11 studies, 0 as a primary outcome
- Spain11 studies, 1 as a primary outcome
- Switzerland11 studies, 1 as a primary outcome
- Germany7 studies, 0 as a primary outcome
- Netherlands7 studies, 1 as a primary outcome
- Sweden7 studies, 2 as a primary outcome
- China6 studies, 1 as a primary outcome
- South Korea6 studies, 0 as a primary outcome
36 countries in all. A study with sites in several counts in each; 9 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed stroke studies that name the Trail Making Test: 25 of 62, 40%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed stroke studies that name the Trail Making Test | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 1, 2% | 776, 10% |
| Results on ClinicalTrials.gov only | 6, 10% | 1,139, 14% |
| A results paper only | 18, 29% | 1,711, 22% |
| Neither | 37, 60% | 4,327, 54% |
The 156 studies
156 studies match. 39 name the Trail Making Test in a primary outcome. Median size 60 participants. Median time to the primary outcome: 5 weeks.
Loading 156 studies; the filters turn on when they arrive.
2026 is partly planned starts.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 2 | 0 |
| 2007 | 1 | 0 |
| 2008 | 2 | 0 |
| 2009 | 3 | 0 |
| 2010 | 1 | 1 |
| 2011 | 2 | 1 |
| 2012 | 2 | 0 |
| 2013 | 6 | 0 |
| 2014 | 2 | 0 |
| 2015 | 4 | 1 |
| 2016 | 6 | 1 |
| 2017 | 13 | 2 |
| 2018 | 8 | 2 |
| 2019 | 10 | 2 |
| 2020 | 10 | 5 |
| 2021 | 10 | 2 |
| 2022 | 14 | 3 |
| 2023 | 16 | 3 |
| 2024 | 11 | 3 |
| 2025 | 18 | 8 |
| 2026 | 15 | 5 |
Library tests named most
Largest condition groups
Phases
Participants
Lead sponsor: industry 14, other 142. Interventional 136, observational 20.
As a primary outcomeSecondary or other outcomeThe Trail Making Test
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07882875 | Start2026 | PhaseObservational | ConditionsStroke, Cardiovascular disease | Participants560 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07865260 | Start2026 | PhaseNot applicable | ConditionsMild cognitive impairment, Stroke, Parkinson's disease | Participants80 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07807176 | Start2026 | PhaseNot applicable | ConditionsStroke | Participants150 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07759791 | Start2025 | PhaseNot applicable | ConditionsStroke | Participants118 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07758257 | Start2025 | PhaseNot applicable | ConditionsStroke | Participants30 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07698444 | Start2021 | PhaseObservational | ConditionsStroke | Participants106 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07682194 | Start2023 | PhaseNot applicable | ConditionsStroke | Participants28 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07668245 | Start2026 | PhaseNot applicable | ConditionsStroke | Participants46 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT07636538 | Start2026 | PhaseNot applicable | ConditionsMild cognitive impairment, Stroke, Parkinson's disease | Participants30 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07624630 | Start2026 | PhaseObservational | ConditionsStroke, Aging, frailty and exercise | Participants50 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07616050 | Start2026 | PhaseNot applicable | ConditionsMild cognitive impairment, Stroke, Parkinson's disease, Multiple sclerosis, Aging, frailty and exercise | Participants70 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07608588 | Start2026 | PhaseNot applicable | ConditionsStroke | Participants45 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07588997 | Start2025 | PhaseNot applicable | ConditionsStroke | Participants18 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07582497 | Start2026 | PhaseNot applicable | ConditionsStroke, Parkinson's disease | Participants60 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07541560 | Start2025 | PhaseNot applicable | ConditionsStroke | Participants90 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07522463 | Start2026 | PhaseNot applicable | ConditionsStroke | Participants44 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07497867 | Start2023 | PhaseObservational | ConditionsStroke | Participants500 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07446062 | Start2026 | PhaseNot applicable | ConditionsStroke, Aging, frailty and exercise | Participants52 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07445841 | Start2026 | PhaseNot applicable | ConditionsStroke | Participants120 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07427511 | Start2026 | PhaseNot applicable | ConditionsStroke | Participants120 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07345481 | Start2026 | PhaseObservational | ConditionsStroke, Brain injury and concussion | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07281313 | Start2025 | PhaseNot applicable | ConditionsStroke | Participants120 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07220538 | Start2025 | PhasePhase 4 | ConditionsStroke | Participants400 | Lead sponsorIndustry | StatusActive, not recruiting | Library tests named
|
| NCT07148453 | Start2025 | PhaseNot applicable | ConditionsStroke | Participants22 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07144930 | Start2025 | PhaseNot applicable | ConditionsStroke, Healthy volunteers | Participants210 | Lead sponsorOther | StatusRecruiting | Library tests named
|
Questions, answered from the data
How many stroke trials use the Trail Making Test?
156 registered stroke studies on ClinicalTrials.gov name it in an outcome measure, 39 of them in a primary outcome: 13% of the condition's 1,233 studies with a cognitive outcome, against 14% of all of them. It is the test stroke trials name most.
Which tests do stroke trials use with the Trail Making Test?
The Digit Span Test (56 studies), the Stroop Color-Word Test (48 studies) and Verbal Fluency (36 studies).
How many participants do phase 2 stroke trials that use the Trail Making Test enroll?
Half of the phase 2 studies that name it enroll 88 participants or fewer, and the middle half enroll 33 to 100. 17 of them give a size.
When do stroke trials measure the Trail Making Test?
Half of the primary outcomes that name the Trail Making Test are measured within 5 weeks of the start, and the middle half from 4 weeks to 13 weeks. 39 primary outcomes give a duration.
How many completed stroke trials that use the Trail Making Test have reported results?
25 of the 62 completed studies that name it, 40%, have reported results: 7 posted them on ClinicalTrials.gov, 19 have a results paper linked to the registry record, and 1 did both. The other 37 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
The census counts Trail Making Test A and Trail Making Test B as one test family, so this page counts their studies together.
Run the Trail Making Test in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.